Xeris Pharmaceuticals' Seed VC Round

Xeris Pharmaceuticals raised a round of funding on November 15, 2005. Investors include Clarus.

Xeris is a specialty biopharmaceutical company focused on developing improved and differentiated injectable therapeutics for multiple indications in diabetes, epilepsy, and immunology. The company's X…

Articles about Xeris Pharmaceuticals' Seed VC Round: